The healthiest thing to drink is likely green tea
This wider distribution is part of why GLP-1 drugs keep finding new candidate indications, though each new tissue claim now demands the same rigorous validation that corrected the earlier record
In STEP 1, 1,961 nondiabetic adults with overweight or obesity achieved an average 14.9% weight loss over 68 weeks when semaglutide was combined with lifestyle changes.20 STEP 2 examined 1210 individuals with T2DM and showed a more modest average weight loss of 9.6%, possibly due to insulin resistance and the influence of other diabetes medications.21 STEP 3 introduced a more intensive lifestyle intervention to participants who were overweight or obese but without T2DMincluding a calorie-restricted diet and behavioral supportand resulted in slightly higher weight loss amongst the 611 study participants, averaging around 16%.22 The STEP 4 trial included 811 individuals who were overweight or obese without diabetes and assessed the impact of discontinuing semaglutide after 20 weeks
In 2017, Lifevantage was served with a warning letter by the FDA for claiming that Protandim can treat certain diseases
Indeed, VPA promotes the transport of glutamine through the mitochondrial membrane, thereby enhancing glutaminase activity
For adults who have struggled with appetite, cravings, insulin resistance, or weight that returns after dieting, GLP-1 treatment may be worth discussing with a qualified clinician